Thomas Hancock

Operates as a special purpose acquisition company

Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases

Develops light-based disinfectant devices and procedures

Develops therapeutics and pharmaceuticals

Provides brokerage services

Provides banking services

Functions as a College/University

NEP focuses on investing in companies in the technology, healthcare, and consumer product industries. Within the technology sector, they concentrate on investing in companies in the Internet, software, hardware and communications industries. In healthcare, they target biopharmaceutical, biotechnology, medical device and e-health companies. In consumer products, they seek companies that can offer distinctive products in a mass-market retail channel setting. The firm seeks early and later stage companies that are beyond the concept stage, have demonstrable technology and evidence of product or service acceptance. For companies with greater financial needs, NEP has a history of syndicating with other reputable venture capital or strategic investors. They participate in all stages of a company's equity financing needs, from a first institutional round of equity to a mezzanine round before an IPO. NEP concentrates on investing in companies that target potentially large markets. In addition, they work closely with portfolio companies in setting goals and financial objectives to maximize the overall financial return of the company and its investors. They seek to invest in companies that offer the potential for a relatively early initial public offering or sale to a strategic buyer. They also assist their portfolio companies in achieving liquidity by way of a sale to a financial investor or through a recapitalization.

Nexus Medical seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of medical technology and life science companies in various stages of development, including medical devices, diagnostics, biotechnology, specialty pharmaceutical and drug discovery tools. They prefer to lead their investments and to work in a hands-on manner with the portfolio companies, committing multiple partners to each investment. It provides financing for seed and early stage capital requirements.

Manufactures medical devices for point-of-care systems, clinical laboratory instruments and analytical laboratory